- Home
- TNGX vs PMI Comparison
TNGX vs PMI Comparison
Compare TNGX & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- PMI
- Stock Information
- Founded
- TNGX 2014
- PMI 1981
- Country
- TNGX United States
- PMI United States
- Employees
- TNGX N/A
- PMI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- PMI
- Sector
- TNGX Health Care
- PMI
- Exchange
- TNGX Nasdaq
- PMI Nasdaq
- Market Cap
- TNGX 723.2M
- PMI 605.1M
- IPO Year
- TNGX N/A
- PMI 2025
- Fundamental
- Price
- TNGX $7.58
- PMI $9.90
- Analyst Decision
- TNGX Strong Buy
- PMI
- Analyst Count
- TNGX 6
- PMI 0
- Target Price
- TNGX $10.00
- PMI N/A
- AVG Volume (30 Days)
- TNGX 2.6M
- PMI 2.2M
- Earning Date
- TNGX 11-05-2025
- PMI 01-01-0001
- Dividend Yield
- TNGX N/A
- PMI N/A
- EPS Growth
- TNGX N/A
- PMI N/A
- EPS
- TNGX N/A
- PMI N/A
- Revenue
- TNGX $24,296,000.00
- PMI $4,461,000.00
- Revenue This Year
- TNGX $20.42
- PMI N/A
- Revenue Next Year
- TNGX N/A
- PMI N/A
- P/E Ratio
- TNGX N/A
- PMI N/A
- Revenue Growth
- TNGX N/A
- PMI 1.36
- 52 Week Low
- TNGX $1.03
- PMI $4.19
- 52 Week High
- TNGX $8.80
- PMI $10.15
- Technical
- Relative Strength Index (RSI)
- TNGX 51.87
- PMI N/A
- Support Level
- TNGX $7.66
- PMI N/A
- Resistance Level
- TNGX $8.80
- PMI N/A
- Average True Range (ATR)
- TNGX 0.51
- PMI 0.00
- MACD
- TNGX -0.04
- PMI 0.00
- Stochastic Oscillator
- TNGX 33.70
- PMI 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.